Trials / Completed
CompletedNCT05829850
An Effectiveness and Safety 6 Months Study of 3 Injections One Week Apart of SYNOLIS VA 40/80 in the Treatment of Symptomatic Knee Osteoarthritis
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 51 (actual)
- Sponsor
- Aptissen SA · Industry
- Sex
- All
- Age
- 35 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
Multicentre, independent assessment study on SYNOLIS VA 40/80 over a period of 24 weeks
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | SYNOLIS VA 40/80 | Three 2mL injections of SYNOLIS VA 40/80, one week apart |
Timeline
- Start date
- 2021-12-29
- Primary completion
- 2023-01-09
- Completion
- 2023-01-09
- First posted
- 2023-04-26
- Last updated
- 2023-04-26
Locations
3 sites across 1 country: Poland
Source: ClinicalTrials.gov record NCT05829850. Inclusion in this directory is not an endorsement.